The Triad of Sleep Disturbance, Perimenopause, and Obesity: An Integrative Review of Current Evidence and Implications for Nursing Practice View PDF

Perimenopause is a natural transitional phase that women exemplified prior to menopause that is demonstrated by fluctuating hormone levels and progressive reproductive aging [1]. Women between the ages of 40 - 55 years typically experience perimenopause, this phase is connected with a wide range of physiological and psychological changes that can greatly affect the health and quality of life of women [2]. Even though vasomotor symptoms such as hot flashes and night sweats are well recognized and documented, other symptoms including sleep disturbances and weight gain are among the most common yet overlooked concerns experienced during the menopausal transition [3].

Sleep plays an essential role in maintaining cardiovascular, endocrine, metabolic and psychological health [4]. The declining progesterone and estrogen levels during perimenopause contributes to the alteration in neurotransmitter activity, thermoregulation, and circadian rhythm, increasing the chances of women experiencing insomnia, fragmented sleep, and poor sleep quality [5]. This disturbance often impacts well beyond nighttime symptoms, inducing daytime fatigue, impaired cognitive functioning, changes in mood, and the reduced the overall quality of life [5].

During perimenopause, many women simultaneously experience progressive weight gain and body fat redistribution from peripheral to central adiposity [6]. Higher risk of obesity and increased fat accumulation is contributed to fluctuations of hormones, reduced physical activity, decreased resting metabolic rate, and changes in appetite regulation [6]. Rising evidence implies that chronic sleep disruption further intensifies these metabolic changes through insulin resistance, increased cortisol secretion, altered leptin and ghrelin regulation, and systemic inflammation. As a consequence, obesity and sleep disturbance appear to harmonize within a complex, feedback loop in which each condition continuously contributes to the development and advancement of the other.

The synergistic effects of obesity, hormonal changes, and sleep disturbance have significant implications on women’s health, including increased risk of depression, anxiety, metabolic syndrome, type II diabetes mellitus, cardiovascular disease and diminished quality of life [7]. Despite the developing recognition of these interlinked conditions, literature often independently examines perimenopause, obesity, and sleep disturbance, leaving a clear need for a rigorous synthesis of current evidence that analyzes their interrelationship.

Throughout the menopausal transition, healthcare professional especially nurses are uniquely positioned to identify women are at risk, implement early education, foster healthier lifestyle interventions, and coordinate multidisciplinary treatment. Increasing knowledge and understanding among hormonal changes, sleep disturbance and obesity can facilitate earlier identification of symptoms and improve evidence-based strategies for clinical management.

This article review examines the current evidence of the relationship between perimenopause, sleep disturbance, and obesity, and examines the physiological mechanisms that link these conditions, analyze evidence-based treatment, and discuss the implications for nursing practice and future research.

Hormonal Changes During Perimenopause

Perimenopause is defined as a natural biological transition for women exemplified by progressive aging of ovaries and the fluctuating of the hormone reproductive levels [1]. Perimenopause is characterized by irregular menstrual cycles, metabolic changes, sleep disturbance, vasomotor symptoms that may last for several years, unlike menopause which is defined as defined retrospectively after 12 consecutive months without menstruation[8]. Declining progesterone and estrogen levels not only affect the reproductive process but also affect numerous physiological processes. The fluctuating of these hormones impact glucose metabolism, energy expenditure, thermoregulation, mood and sleep regulation, increasing the vulnerability of women to chronic health conditions [9].

Estrogen plays an essential role in maintaining metabolic homeostasis by regulating insulin sensitivity, cardiovascular function and fat distribution [10]. Despite the minimal overall body weight changes, the declining of estrogen levels increases the risk for women to experience an increase in visceral adiposity and reduction in lean muscle mass [10]. Simultaneously, the declining progesterone production may contribute to sleep disruption, anxiety, and reduction in relaxation because of the effect it has on neurotransmitter activity within the central nervous system [11]. Collaborative of the changes of these hormones create a physiological environment that causes women to be predispose to both obesity and sleep disturbance [11]. The foundation is set for examining why the disturbance of sleep becomes most prevalence during menopausal transition by understanding of these hormonal changes.

Sleep Disturbance During Perimenopause

During perimenopausal transition sleep disturbance is one of the most chief complaint and distressing symptoms reported, but women in the menopausal transition only half are affected [12]. Even though insomnia has been identified as the most common chief complaint reported, the disruption in sleep comprises a range of symptoms including difficulty falling asleep, frequent nighttime awakenings, early morning awakening, and nonrestorative sleep [12]. These disturbances of sleep are often multifactorial, attributing from vasomotor symptoms, hormonal fluctuations, psychological stress, and aged -related changes in sleep architecture [13].

Decreased levels of estrogen have been linked with alterations in thermoregulations that attribute to hot flashes and night sweats, both which frequently sleep interruption [14]. In addition, decrease progesterone level may reduce the natural sedative effects of the hormone, effecting women ability to achieve restorative sleep [14]. Rising evidence also suggests melatonin secretion and circadian rhythm regulation changes also contribute to poor quality of sleep during perimenopause.

Persistent disruption in sleep extends beyond nighttime symptoms and has been aligned with impaired concentration, fatigue, decrease work productivity, mood disturbances, and reduced quality of life [13]. As evidence continues to accumulate, sleep disturbance has been increasingly recognized by researchers as a contributor to metabolic dysfunction rather than simply a symptom of changes in hormones. Emerging evidence not only suggest that chronic sleep disruption during perimenopause affects daily functioning but also contributes to metabolically changes that increase the risk of obesity.

Obesity and Metabolic Changes During Perimenopause

Obesity has been deemed as an essential health concern with midlife menopausal women representing a period of increased vulnerability to weight gain and adverse metabolically changes [7]. Although chronological aging contributes to the progressive increase in body weight, hormonal changes associated with perimenopause appear to elevate the redistribution of adipose tissue toward visceral or central accumulation of fat [15]. This shift in body composition is clinically significant because visceral adiposity is strongly implicated with hypertension, cardiovascular disease, systemic inflammation, insulin resistance, and dyslipidemia [15].

There are several physiological mechanisms that contribute to weight gain during perimenopause. Decrease levels of estrogen reduces resting energy expenditure and causes alteration in lipid metabolism, while changes in appetite regulation cause a caloric intake increase [16]. Simultaneously reduction in lean muscle mass further decreases metabolic rate, making weight management progressively more challenging [16]. These changes together create an environment in which subtle modification in physical activity or diet may result in profound weight gain.

Literatures consistently highlights that during perimenopause, obesity is connected with increased risk of chronic disease and reduced quality of life, emphasizing the significant of early identification and preventive management. Researchers in recent years have shifted their focus from exploring perimenopause symptoms of sleep disturbance and obesity as separate conditions to understanding their complex and reciprocal relationship.

The Interrelationship Between Sleep Disturbance and Obesity

Current evidence corroborates a bidirectional relationship between obesity and sleep disturbance, indicating that each condition fosters the development and progression of the other [17]. During perimenopause, hormonal fluctuations exhibit to amplify this relationship by modifying metabolic, endocrine, and inflammatory pathways [17]. Consequently, many women experience chronic sleep disruption have a greater risk for gaining weight, while obesity itself may further impair the quality of sleep.

Sleep deprivation has been associated with increased impaired glucose metabolism, cortisol secretion, dysregulation of appetiteregulating hormones such as ghrelin and leptin [18]. Fat storage is promoted by elevated cortisol, especially within the abdominal region, while alteration in ghrelin and leptin increases hunger and caloric intake [19]. These physiological manifests contribute to chronic inflammation, insulin resistance, and escalating weight gain. In juxtaposition, obesity increases the risk of obstructive sleep apnea and fragmentation of sleep, creating a cycle in which poor quality of sleep and metabolic dysfunction mutually reinforce one another [19].

Obesity and sleep disturbance should be viewed as interlink manifestations of physiological changes rather than representing isolated health concerns during perimenopause. Recognizing this relationship is important for the development of comprehensive strategies that focus both on management of symptoms and longterm disease prevention. In light of the multifactorial nature of these conditions, metabolic health, evidenced-based treatment management that address quality of sleep, and lifestyle behaviors are essential for improving outcomes perimenopausal women.